These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14584210)

  • 61. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Outpatient clinic--therapy of withdrawal state, rehabilitation of patients with alcoholism].
    Kosugi Y
    Nihon Rinsho; 1997 Feb; 55 Suppl():422-6. PubMed ID: 9078767
    [No Abstract]   [Full Text] [Related]  

  • 64. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
    Dahchour A; De Witte P
    Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of placebo in the alcohol withdrawal state.
    Lichtigfeld FJ; Gillman MA
    Alcohol Alcohol; 1989; 24(2):109-12. PubMed ID: 2655625
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Reports from the Federal Conference of German Psychiatry and Psychotherapy Clinics].
    Längle G; Pollmächer T
    Psychiatr Prax; 2013 Apr; 40(3):164-5. PubMed ID: 23559448
    [No Abstract]   [Full Text] [Related]  

  • 67. [Realities of alcohol withdrawal].
    Paille F; Moirand R
    Rev Prat; 2015 Jun; 65(6):845-6. PubMed ID: 26298916
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of alcohol dependence.
    Kranzler HR
    Liver Transpl Surg; 1997 May; 3(3):311-21. PubMed ID: 9346757
    [No Abstract]   [Full Text] [Related]  

  • 69. Therapeutics for alcoholism: what's the future?
    Lawrence AJ
    Drug Alcohol Rev; 2007 Jan; 26(1):3-8. PubMed ID: 17364830
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The efficacy and mechanisms of action of lerivon in alcoholism].
    Ivanets NN; Anokhina IP; Kogan BM; Chirko VV; Nebarakova TP; Rusinov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(5):52-8. PubMed ID: 9012256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intellectual impairment among recently abstinent alcohol abusers.
    O'Mahony JF; Doherty B
    Br J Clin Psychol; 1996 Feb; 35(1):77-83. PubMed ID: 8673037
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Relapse prevention group for alcohol dependent patients].
    Johann M; Bobbe G; Franke E; Wodarz N
    Psychiatr Prax; 2003 May; 30 Suppl 2():S125-8. PubMed ID: 14509057
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Alcoholism: relapse prevention].
    Pelc I
    Rev Med Brux; 1997 Sep; 18(4):272-6. PubMed ID: 9411660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nifedapine for protracted withdrawal syndrome.
    Katta BB
    Can J Psychiatry; 1991 Mar; 36(2):155. PubMed ID: 2044037
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacotherapy of alcoholism--10 years of progress.
    Anton RF
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):172A-175A. PubMed ID: 8947259
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacotherapy and psychotherapy for the treatment of alcoholism in Germany.
    Soyka M
    Drug Alcohol Depend; 1995 Sep; 39 Suppl 1():S9-13. PubMed ID: 8565796
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Not Available].
    Saissi F; Caflisch C
    Praxis (Bern 1994); 2017; 106(10):503-510. PubMed ID: 28488530
    [No Abstract]   [Full Text] [Related]  

  • 78. Treating the "unhealthy alcohol user" on medical wards: beyond withdrawal.
    Rivest J; Jutras-Aswad D; Shapiro PA
    J Psychiatr Pract; 2013 May; 19(3):213-26. PubMed ID: 23653078
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Somatic configuration: a model for an integrated approach to the understanding of disease.
    Margaron H
    Subst Use Misuse; 2007; 42(14):2183-92. PubMed ID: 18097999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psychotherapeutic considerations in pharmacological trials.
    O'Malley SS; Carroll KM
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):17A-22A. PubMed ID: 8904990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.